期刊文献+

18种分枝杆菌标准菌株的分枝菌酸指纹谱比较 被引量:7

A comparison study on clinical chromatographic fingerprintings of mycolic acids analysis of 18 standard strains of Mycobacteria in China
原文传递
导出
摘要 目的用本实验室所建立的高效液相色谱分枝菌酸分析方法,构建18种分枝杆菌标准菌株的分枝菌酸指纹谱库,并对该库的分枝菌酸指纹谱进行比较。方法标准菌株按常规方法,分别转种到改良罗氏培养基斜面上培养,待菌落形成后,用化学法从培养物中提取细胞壁的分枝菌酸,经皂化、酸化和衍生后,制备出良好的分析样品,用于色谱检测分析。结果成功地构建了18种分枝杆菌标准菌株的分枝菌酸指纹谱库,该指纹谱的重复性日内变异系数为0.20%-0.83%,均<1%。每种分枝菌酸的指纹谱都具有各自的特征,峰形也有一定规律。根据峰形的特点将其分为3类:A类(单组峰)包括结核、牛、戈登、爱知、堪萨斯、海分枝杆菌和卡介苗,B类(2组峰)包括蟾蜍、土地、新金色、不产色和浅黄分枝杆菌,C类(3组峰)包括胞内、鸟、金色、偶然、副偶然、脓肿和耻垢分枝杆菌。结论依据18种分枝杆菌标准菌株的分枝菌酸指纹谱,即可对分枝杆菌菌种进行鉴定。卡介苗与牛分枝杆菌的分枝菌酸指纹谱的峰形存在很大差别,该现象很可能作为结核病潜伏感染和分枝杆菌耐药机制的一种新理论依据。 Objective A clinical chromatographic fingerprinting of 18 standard strains of Mycobacteria commercialized in China by high-performance liquid chromatography approach was developed and improved in this laboratory. A comparison of clinical chromatographic fingerprintings of mycolic acids was carried out. Methods Mycolic acids were extracted from whole cultured cells of Mycobacteria by biochemical methods, and then samples was prepared for analysis after the mycolic acids were saponified, acidified and derived. The samples were detected by high-performance liquid chromatography under optimum conditions. Results Using above techniques a clinical chromatographic fingerprinting of Mycolic acids analysis was successfully established. The repeatability of the mycolic acids fingerprinting was evaluated. Coefficient of variation (CV) of chromatographic fingerprinting was between 0. 20% -0. 83%. Conclusions The first clinical chromatographic fingerprinting of 18 standard strains of Mycobacteria in China was established in this laboratory. Mycobacteria can be accurately identified according to chromatographic fingerprinting in a short time. Moreover, there was significant difference between BCG vaccine and Mycobacterium bevis when their peak was compared, which may lead to research of new tools for identifying insidious infection of tuberculosis and for the study of the mechanism of drug tolerance.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2006年第7期470-473,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 天津市卫生局重点基金资助项目(99KY012)
关键词 色谱法 高压液相 分枝杆菌属 分枝菌酸 Chromatography, high pressure liquid Mycobacterium Mycolic acids
  • 相关文献

参考文献11

  • 1Tortoli E, Bartoloni A, Bottger EC, et al. Burden of unidentifiable mycobactefia in a reference laboratory. J Clin Microbiol, 2001,39:4058-4065.
  • 2Piersimoni C, Goteri G, Nista D, et al. Mycobaterium lentiflavum as an emerging causative agent of cervical lymphadenitis. J Clin Microbiol, 2004,42:3894-3897.
  • 3Laval F, Laneelle MA, Deon C, et al. Accurate molecular mass determination of mycolic acids by MALDI-TOF mass spectrometry.Anal Chem, 2001,73:4537-4544.
  • 4Minnikin DE, Minnikin SM, Hutchinson IG, et al. Mycolic acid patterns of representative strains of Mycobacterium fortuitum,‘Mycobacterium peregrinum' and Myco-bacterium smegmatia. J Gen Microbiol, 1984,130:363-367.
  • 5Butler WR, Guthertz LS. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species.Clin Microbiol Rev, 2001,14:704-726.
  • 6Watanabe M, Aoyagi Y, Ridell M, et al. Separation and characterization of individual mycolic acids in representative mycobateria. Microbiology, 2001,147 : 1825-1837.
  • 7Kellogg JA, Bankert DA, Withers GS, et al. Application of the Sherlock Mycabacteria Identification System using high-performance liquid chromatography in a clinical laboratory. J Clin Microbiol,2001,39:964-970.
  • 8Butler WR, Floyd MM, Silcox V, et al. Standardized method for HPLC identification of mycobacteria. Atlanta: Centers for Disease Control and Prevention, U.S. ,1996.5-23.
  • 9Walkiewicz R, Safianowska A, Grubek-Jaworska H, et al. Use of mycolic acids analysis in diagnosis of tuberculosis and mycobateriosis-three-year experience. Pneumonol Alergol Pol,2002,70:444-449.
  • 10Tortoli E, Bartoloni A, Garzelli C, et al. Unusual high-performance liquid chromatography profile of a strain of Mycobacterium avium.Clin Microbiol Infect, 2000,6:568-569.

二级参考文献19

  • 1Dietrich G, Viret JF, Hess J. Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments. Vaccine, 2003,21:667-670.
  • 2Orme IM. The latent tuberculosis bacillus( I'll let you know if ever meet one). Int J Tuberc Lung Dis,2001,5:589-593.
  • 3Riska PF, Carleton S. Latent tuberculosis: models, mechanisms,and novel prospects for eradication. Semin Pediatr Infect Dis, 2002,13 : 263-272.
  • 4Phyu S, Mustafa T, Hofstad T, et al. A mouse model for latent tuberculosis. Scand J Infect Dis, 1998, 30:59-68.
  • 5de Wit D, Wootton M, Dhillon J, et al. The bacterial DNA content of mouse organs in the Comell model of dormant tuberculosis. Tuber Lung Dis,1995,76:555-562.
  • 6Orme IM. A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis, 1988,137:716-718.
  • 7Howard AD, Trask OJ, Weisbrode SE, et al. Phenotypic changes in T cell populations during the reactivation of tuberculosis in mice.Clin Exp Immunol, 1998, 111:309-315.
  • 8Howard AD, Zwilling BS. Cytokine production by CD4 and CD8 T cells during the growth of Mycobacterium tuberculosis in mice. Clin Exp Immunol, 1998, 113:443-449.
  • 9Howard AD, Zwilling BS. Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin Exp Immunol,1999, 115:428-434.
  • 10Flynn JL, Scanga CA, Tanaka KE, et al. Effects of aminoguanidine on latent murine tuberculosis. J Immunol, 1998,160:1796-1803.

共引文献16

同被引文献53

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部